WhitTier Trust Company’s Arvinas ARVN Stock Holding History

WhitTier Trust Company’s Portfolio ARVN Stock Details ARVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-145	Closed	-$1.72K	–	1415
2025 Q4	$1.72K	Hold	145	–	–	﹤0.01%	1183
2025 Q3	$1.39K	Hold	145	–	–	﹤0.01%	1194
2025 Q2	$1.07K	Buy	+145	New	+$1.07K	﹤0.01%	1354

Other funds holding ARVN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Pfizer New York $170M AUM 191.09% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

WhitTier Trust Company's ARVN Position: Q1 2026 in Review

WhitTier Trust Company sold out of Arvinas (ARVN) in Q1 2026, closing a stake of 145 shares — an estimated $1.72K sold.

WhitTier Trust Company first reported a position in ARVN in Q2 2025 and held it in 3 quarters. The position peaked at $1.72K in Q4 2025. 207 funds tracked by Wall St. Rank hold ARVN as of Q1 2026.

WhitTier Trust Company reported no remaining Arvinas position as of Q1 2026 after selling out during the quarter.
WhitTier Trust Company sold 145 Arvinas shares in Q1 2026, an estimated $1.72K.
WhitTier Trust Company first reported a position in Arvinas in Q2 2025 and held it in 3 quarters.
WhitTier Trust Company's Arvinas position peaked at $1.72K in Q4 2025.
207 funds tracked by Wall St. Rank held Arvinas as of Q1 2026.

Based on WhitTier Trust Company's 13F filing for Q1 2026, filed 28 Apr 2026.